These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 23945874)

  • 1. Are GPCRs still a source of new targets?
    Garland SL
    J Biomol Screen; 2013 Oct; 18(9):947-66. PubMed ID: 23945874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GPCR structures in drug design, emerging opportunities with new structures.
    Tautermann CS
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4073-9. PubMed ID: 25086683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging opportunities for allosteric modulation of G-protein coupled receptors.
    Wang CI; Lewis RJ
    Biochem Pharmacol; 2013 Jan; 85(2):153-62. PubMed ID: 22975406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric ligands for G protein-coupled receptors: a novel strategy with attractive therapeutic opportunities.
    De Amici M; Dallanoce C; Holzgrabe U; Tränkle C; Mohr K
    Med Res Rev; 2010 May; 30(3):463-549. PubMed ID: 19557759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [G-protein-coupled receptors plasticity and signalling].
    Galés C
    Med Sci (Paris); 2012 Oct; 28(10):883-5. PubMed ID: 23067421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A structural chemogenomics analysis of aminergic GPCRs: lessons for histamine receptor ligand design.
    Kooistra AJ; Kuhne S; de Esch IJ; Leurs R; de Graaf C
    Br J Pharmacol; 2013 Sep; 170(1):101-26. PubMed ID: 23713847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The 7 TM G-protein-coupled receptor target family.
    Jacoby E; Bouhelal R; Gerspacher M; Seuwen K
    ChemMedChem; 2006 Aug; 1(8):761-82. PubMed ID: 16902930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Informed development of drugs acting at family B G protein-coupled receptors.
    Miller LJ
    Ann N Y Acad Sci; 2008 Nov; 1144():203-9. PubMed ID: 19076378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fingolimod (FTY720): a recently approved multiple sclerosis drug based on a fungal secondary metabolite.
    Strader CR; Pearce CJ; Oberlies NH
    J Nat Prod; 2011 Apr; 74(4):900-7. PubMed ID: 21456524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definition of the G protein-coupled receptor transmembrane bundle binding pocket and calculation of receptor similarities for drug design.
    Gloriam DE; Foord SM; Blaney FE; Garland SL
    J Med Chem; 2009 Jul; 52(14):4429-42. PubMed ID: 19537715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. X-ray structural information of GPCRs in drug design: what are the limitations and where do we go?
    Topiol S
    Expert Opin Drug Discov; 2013 Jun; 8(6):607-20. PubMed ID: 23537065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs.
    Congreve M; Oswald C; Marshall FH
    Trends Pharmacol Sci; 2017 Sep; 38(9):837-847. PubMed ID: 28648526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biased ligands for better cardiovascular drugs: dissecting G-protein-coupled receptor pharmacology.
    DeWire SM; Violin JD
    Circ Res; 2011 Jul; 109(2):205-16. PubMed ID: 21737816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ligand and decoy sets for docking to G protein-coupled receptors.
    Gatica EA; Cavasotto CN
    J Chem Inf Model; 2012 Jan; 52(1):1-6. PubMed ID: 22168315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time-resolved FRET strategy to screen GPCR ligand library.
    Oueslati N; Hounsou C; Belhocine A; Rodriguez T; Dupuis E; Zwier JM; Trinquet E; Pin JP; Durroux T
    Methods Mol Biol; 2015; 1272():23-36. PubMed ID: 25563174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GLIDA: GPCR-ligand database for chemical genomic drug discovery.
    Okuno Y; Yang J; Taneishi K; Yabuuchi H; Tsujimoto G
    Nucleic Acids Res; 2006 Jan; 34(Database issue):D673-7. PubMed ID: 16381956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [G-protein-coupled receptors targeting: the allosteric approach].
    Sebag JA; Pantel J
    Med Sci (Paris); 2012 Oct; 28(10):845-51. PubMed ID: 23067415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From purified GPCRs to drug discovery: the promise of protein-based methodologies.
    Alkhalfioui F; Magnin T; Wagner R
    Curr Opin Pharmacol; 2009 Oct; 9(5):629-35. PubMed ID: 19443270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-inspired design of β-arrestin-biased ligands for aminergic GPCRs.
    McCorvy JD; Butler KV; Kelly B; Rechsteiner K; Karpiak J; Betz RM; Kormos BL; Shoichet BK; Dror RO; Jin J; Roth BL
    Nat Chem Biol; 2018 Feb; 14(2):126-134. PubMed ID: 29227473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.